Tumoral TP53 and/or CDKN2A alterations are not reliable prognostic biomarkers in patients with localized Ewing sarcoma: A report from the Children's Oncology Group

for the Children's Oncology Group Ewing Sarcoma Biology Committee

Research output: Contribution to journalArticlepeer-review

22 Scopus citations

Fingerprint Dive into the research topics of 'Tumoral TP53 and/or CDKN2A alterations are not reliable prognostic biomarkers in patients with localized Ewing sarcoma: A report from the Children's Oncology Group'. Together they form a unique fingerprint.

Medicine & Life Sciences